Illuminant Surgical

Illuminant Surgical, headquartered in Culver City, CA, with an additional location in Cambridge, MA, operates within the healthcare industry, focusing on the medical devices sub-industry. The company, which is part of the Y Combinator S22 batch, employs a team of four and serves regions across the United States, including remote areas. Illuminant Surgical’s technology integrates computer vision and low-cost hardware to project patient-specific anatomical structures, pre-operative annotations, and real-time surgical feedback such as needle depth and tool trajectory directly onto the patient’s skin. This innovation aims to improve the safety and efficiency of surgeries, particularly in underserved health systems and various surgical specialties. Founded with the revolutionary idea of projecting x-ray images directly onto patients, the company has formed significant partnerships with institutions like Stanford University, M2D2, Houston Methodist, and Mount Sinai Hospital. Selected from 19,000 applications to participate in Y Combinator’s S22 batch, where only 9% were healthcare companies, Illuminant Surgical is set to present its advancements to an exclusive group of investors at YC’s 35th Demo Day.